Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
A Study of Camizestrant and Ribociclib for Patients with Hormone Receptor-Positive Breast Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Evaluating tirzepatide and letrozole for reducing tumor growth in postmenopausal hormone‑receptor‑positive breast cancer patients
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study on Everolimus and Exemestane for Patients with Metastatic Breast Cancer
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing 18F-FDG and 68Ga-FAPI-46 for PET Scans in Patients with Hormone-Positive Breast Cancer
Not yet recruiting
Investigated Diseases:
Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
+6
Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
Not recruiting
Investigated Drugs:
+5
Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer
Not recruiting
Investigated Drugs: